Clinical Trial Update: Vaginal lIve Biotherapeutic RANdomized Trial [EARLY_Phase 1]

View source ↗

Summary

An early-phase, randomized trial evaluating a vaginal live biotherapeutic for bacterial vaginosis sponsored by Massachusetts General Hospital has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bacterial Vaginosis | EARLY_Phase 1 | Status: COMPLETED